End stage kidney disease hyperkalemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Maintenance hemodialysis patients receiving hemodialysis three times a week Patients undergoing treatment for hyperkalemia with resin Patients who have obtained written informed consent of their own free will to participate in this study
Exclusion criteria
Exclusion criteria: Patients allergic to sodium zirconium cyclosilicate hydrate Patients who are breastfeeding or pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in serum potassium levels before and after switching from cation exchange resin to sodium zirconium cyclosilicate hydrate | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of electrolyte values before and after switching from cation exchange resin to zirconium sodium cyclosilicate hydrate Comparison of bicarbonate concentration before and after switching from cation exchange resin to zirconium sodium cyclosilicate hydrate Comparison of Geriatric Nutritional Risk Index (GNRI) values before and after switching from cation exchange resin to zirconium sodium cyclosilicate hydrate | — |
Countries
Japan
Contacts
Saitama Sekishinkai Hospital Department of Nephrology